BNGO

Bionano Genomics, Inc.

$1.23

6.03%
SectorHealthcareIndustryMedical Instruments & SuppliesCountryUnited States

Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants.

Source: Yahoo Finance
AI summary

Price & performance

1M-28.0%
3M+10.2%
YTD-21.7%
1Y-37.1%
52-week range—
Beta1.42
Full chart and returns against a benchmark

Q-Score

24/ 100

Quality against peers; 50 is the peer median.

Growth33
Risk32
Performance15
Valuation48
Profitability31
Leverage33
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$28.5M-7.4%
Net income-$26.4M
Net margin-92.6%+271.4 pts
Historical fundamentals

Red flags in filings

1active red flag
Going-concern doubtMar 23, 2026
Filings, findings and the timeline

Revenue exposure

EMEA49%
Americas43%
Asia Pacific8%
Regions, segments, customers and suppliers

Valuation

BNGOIndustryP/E—49.36P/S0.573.73EV/EBITDA—23.12P/B0.543.92PEG——
Dividend yield0.00%
Every valuation metric

Earnings

Nov 10next report, after the close
EPS estimate$-0.45
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate